Pressure Mounting on CMS to Delay Ban on Home Delivery of DTS

By Michael Rule, Manager of Public Affairs and Grassroots Advocacy

With the July 1 implementation of the national mail order (NMO) program rapidly approaching, Representative Mike McIntyre (D-NC) became the 44th member of the House of Representatives to raise concerns with the Centers for Medicare and Medicaid Services (CMS). If implemented, the NMO would ban independent pharmacists from providing home delivery of diabetes testing supplies (DTS) to Medicare Part B beneficiaries.

In his letter, Representative McIntyre noted that “I am concerned that implementation would negatively impact the quality of care in rural areas like those in my district, and that is simply unacceptable. It is essential that we ensure adequate access of care for those in need.” He further requested CMS to provide information to his office surrounding their decision and whether a review would take place prior to implementation.

His letter follows a joint letter to CMS signed by 43 members of the House, which questioned CMS’ reasoning for the rule. Those lawmakers wrote, “Now that retail and mail order suppliers receive the same level of reimbursements, we believe there is no further reason to prohibit home delivery by retail pharmacies. We ask that you expeditiously consider allowing small retail pharmacies to continue home delivery and not prevent these crucial face-to-face counselling and adherence services from being available to Medicare patients.”

In addition, patient stories are beginning to emerge indicating the potential inconvenience and harm that this policy change may have on patients. South Dakota’s Keloland TV recently profiled a senior husband and wife who both have diabetes. Neither can drive so they rely on their independent community pharmacy, Lewis Drug pharmacy, for delivery of their testing supplies and medication. The husband, Herb Grogan, told the station of the value he places on trusting his health needs to someone local who “understands me and my medical condition.”

With bipartisan pressure mounting, it is prudent for CMS to reexamine this delivery prohibition decision to ensure patients maintain access to their testing supplies through a provider they know and trust. In the absence of CMS action, bipartisan legislation, H.R. 2375, has also been introduced that would delay the implementation of the NMO by six months to give Congress time to study the potential negative impact on patient care.

Visit the NCPA Legislative Action Center to look up the contact information for your members of Congress and call to urge them support this legislation and act where CMS has thus far failed to do so.

4 Responses to “Pressure Mounting on CMS to Delay Ban on Home Delivery of DTS”

  1. 1 Anand Kumar July 2, 2013 at 2:52 pm

    Did the ban on Home Delivery of DTS went effective on July 1st?

    • 2 ncpa1 July 9, 2013 at 10:22 am

      Yes, unfortunately, it did take effect July 1. Help NCPA convince the U.S. Centers for Medicare & Medicaid Services (CMS) and Congress of the shortcomings in this policy, to which NCPA strenuously and repeatedly objected. We ask you to take two steps.

      First, please share your patient complaint stories either through the online NCPA complaint form or by emailing us. Second, please encourage beneficiaries to air their complaints directly with CMS by calling 1-800-MEDICARE or by completing the online complaint form.

  2. 3 CJ Stredler July 3, 2013 at 11:16 am

    Our pharmacy has been delivering at no charge, scripts and DTS supplies to our patients for 20 years. We discovered years ago that there are many patients and most certainly LTC folks who cannot pick up their meds and/or DTS. We accept assignment, we paid to become a DMEPOS provider and I just don’t understand how CMS can come up with face to face pick up only for test strips patients. There is something not right going on here. I suspect it has something to do with lobbyists for mail order companies. Have you seen their Ads plastered on every TV network?

    • 4 ncpa1 July 9, 2013 at 10:24 am

      Yes, NCPA agrees that Medicare’s ban on DTS deliveries makes no sense. At this point, NCPA’s efforts are focused on documenting the problems experienced by patients to fuel efforts to overturn this controversial policy. If you are aware of patient problems please report them to NCPA online or by emailing us, and encourage beneficiaries to report them directly to CMS by calling 1-800-MEDICARE or by completing the online complaint form.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Search by Categories

%d bloggers like this: